Skip to main content

Table 3 Baseline characteristics

From: Dual anti-platelet therapy following percutaneous coronary intervention in a population of patients with thrombocytopenia at baseline: a meta-analysis

Studies

Age

Males

T2DM

HTN

Smoking

DYS

TC/NTC

TC/NTC

TC/NTC

TC/NTC

TC/NTC

TC/NTC

Ayoub 2018 [8]

68.8/69.3

73.1/73.9

45.9/46.9

77.1/77.9

–

–

Ito 2018 [9]

71.8/68.0

79.5/72.9

44.4/39.6

81.5/81.8

21.2/28.6

39.7/42.3

Kiviniemi 2013 [10]

74.0/73.0

85.0/68.0

31.0/37.0

76.0/85.0

6.00/11.0

69.0/66.0

Liu 2018 [11]

60.9/57.9

13.5/24.5

35.2/29.3

60.9/64.8

59.3/56.2

65.5/67.5

Overgaard 2008 [12]

67.0/63.0

84.5/71.5

32.2/26.9

61.7/61.3

46.0/38.0

–

Raphael 2016 [13]

70.6/67.4

82.0/71.0

44.0/30.0

85.0/80.0

–

84.0/85.0

Shiraishi 2019 [14]

74.0/72.0

74.8/73.4

53./43.8

77.4/75.9

11.9/16.2

60.6/66.5

Yadav 2016 [15]

65.7/61.9

87.3/73.8

32.0/23.5

67.7/61.1

26.9/36.0

57.9/51.5

  1. Abbreviations: T2DM type 2 diabetes mellitus, HTN hypertension, DYS dyslipidemia, TC thrombocytopenia group, NTC non-thrombocytopenia group